^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
VarMap™ Pan-Cancer NGS Panel

Company:
NuProbe
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
VarMap™ Pan-Cancer NGS Panel is a comprehensive cancer mutation liquid biopsy panel to detect 0.1% VAF on the MiniSeq and MiSeq requiring only 1M reads. It covers 337 hotspots in 61 genes with clinical high-significance in many cancer types and includes detection of over 6500 COSMIC mutations including JAK2 V617F, BRAF V600E, KRAS G12D/G12V/G12C, EGFR exon 19 deletions and insertions, EGFR T790M, EGFR L858R, and TP53 R248Q. The VarMapTM Pan-Cancer NGS Panel enables highly sensitive mutation detection and quantitation for cancer patients.
Cancer:
Leukemia, Lymphoma, Solid Tumor
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), AR (Androgen receptor), ATM (ATM serine/threonine kinase), BRAF (B-raf proto-oncogene)
See More ...
Method:
Next-Generation Sequencing (NGS)